Latest News and Press Releases

MELBOURNE, AUSTRALIA--(Marketwired - Sep 22, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company" ) is pleased to announce that it has signed a binding contract of sale for its...

MELBOURNE, AUSTRALIA--(Marketwired - Sep 15, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") is pleased to announce plans for the restructure and realignment of group...

MELBOURNE, AUSTRALIA--(Marketwired - Aug 26, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that the United States District Court for the Middle District of...

BRISBANE, AUSTRALIA--(Marketwired - Aug 25, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, announced today the appointment of Ms. Jenni Pilcher as its Chief Financial...

CAMBRIDGE, MA--(Marketwired - Jul 30, 2014) -  Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with...

MELBOURNE, AUSTRALIA--(Marketwired - Jul 7, 2014) -  Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that the number of...

CAMBRIDGE, MA--(Marketwired - Jun 30, 2014) - Proteostasis Therapeutics, Inc., a developer of novel therapeutics regulating protein homeostasis to improve outcomes for patients with orphan and...

BRISBANE, AUSTRALIA--(Marketwired - Jun 20, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that the first patient has been enrolled into the new...

BRISBANE, AUSTRALIA--(Marketwired - Jun 5, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, announced today that they expect to report the top-line results from the...

MELBOURNE, AUSTRALIA--(Marketwired - May 28, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce the appointment of Mr Eutillio Buccilli to the role of Chief...